The Expanding Role Of Integrative Medicine In Cancer Treatment
MUNICH, June 27, 2012 /PRNewswire-USNewswire/ -- Cancer is an insidious disease that often finds ways to defeat the most advanced treatments. As a result, the scientific and medical communities have become increasingly aware that a multi-pronged approach is the best way to beat cancer. On June 16-17, at the Second International Congress on Complementary Oncology in Munich, Germany, integrative medicine pioneer Isaac Eliaz, M.D. joined leading experts in the field of complementary oncology. During his visit, he shared research advancements demonstrating how integrative therapies can boost our abilities against cancer.
"It was a privilege to speak to such a receptive audience at the Germany International Congress on Complementary Oncology. This conference provides a wonderful opportunity to share important information on integrative treatments and learn about new strategies to defeat cancer," says Dr. Eliaz. "Having the opportunity to give two separate presentations on each day of the congress allowed me to cover a wider array of important topics."
In his first presentation, delivered on June 16, Dr. Eliaz outlined the case against Galectin-3, a protein that has been widely implicated in cancer, heart disease and other conditions. The presentation, Galectin-3 and the Role of Modified Citrus Pectin in Cancer and Beyond, unraveled the biology of Galectin-3 and why its overabundance can so dramatically contribute to disease. Galectin-3 is a "culprit" biomarker that promotes metastasis and has additional value in predicting the outcome of disease--the more Galectin-3 in the body, the lower the overall survival rates. A new FDA approved blood test can easily measure Galectin-3 levels in the blood, serving as an important tool in determining risk and prognosis of numerous diseases related to elevated Galectin-3. In cancer, Galectin-3 plays a role in cell to cell adhesion, cancer cell aggregation, tumor growth, metastasis, angiogenesis and the inhibition of programmed cell death (apoptosis) -- a veritable perfect storm of conditions for the advancement of cancer.
Derived from citrus peels, Modified Citrus Pectin (MCP) is a powerful Galectin-3 antagonist. Dr. Eliaz presented research on how MCP binds to Galectin-3 and blocks cancer cell aggregation, as well as interactions that cause angiogenesis (growth of new blood vessels to the tumor) and metastasis. In addition, MCP complements chemotherapy, protects against radiation damage, and enhances the immune system.
"Study after study has demonstrated that elevated Galectin-3 levels in the body fuel the formation and progression of cancer and other chronic diseases," says Dr. Eliaz. "Modified Citrus Pectin is thus earning an important reputation among doctors and researchers as a powerful natural Galectin-3 inhibitor."
The next day, Dr. Eliaz presented Integrative Approaches to Prostate Cancer, during which he outlined a wide array of diagnostic tests to detect prostate cancer early, before it can spread. He went on to discuss how MCP, medicinal mushrooms, honokiol (derived from magnolia bark), specific botanicals and other natural agents can bolster the immune system against prostate cancer, support hormone balance and, in some cases, act directly against the disease. Dr. Eliaz presented studies which showed how MCP and other natural compounds suppressed invasive prostate cancers. In this lecture, Dr. Eliaz also presented a comprehensive model of the ongoing dialogue between health and disease. He demonstrated how mind-body medicine can be integrated into such a model, resulting in profound health benefits for the patient on all levels.
"Complementary cancer therapies, like all cancer treatments, must be part of a comprehensive, multi-layered approach against cancer," says Dr. Eliaz. "As new data demonstrates the ability of botanical formulas and natural compounds to target specific features of aggressive cancer, we must do more to integrate these agents into highly strategic treatment protocols."
As a pioneer in integrative medicine,Dr. Eliaz has been treating cancer and chronically ill patients for more than 25 years, drawing on his extensive training in a diverse range of medical systems. By integrating Western and complementary protocols, botanical and nutritional therapies, mind-body medicine and multiple healing modalities, Dr. Eliaz specializes in individualized care that is unique to each patient's preferences and needs.
About Better Health Publishing:
Better Health Publishing (BHP) focuses on the publication of key works promoting health and wellness. BHP believes that education and accessible information are the core components of a healthy and sustainable society.
This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com.
SOURCE Better Health Publishing
More by this Source
Honokiol Inhibits Aggressive Renal Cell Cancer
Apr 09, 2014, 06:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.